The Unknown Limits of Synthetic Biology
By Helia Ighani,
Council on Foreign Relations
| 02. 13. 2015
Untitled Document
Since 2001, major metropolitan cities have increasingly conducted gas and chemical attack simulations in subway systems. Police departments carry out these exercises with odorless, colorless, and non-toxic gases to determine how to evacuate passengers in the event of an actual biological or chemical attack, and identify safeguards that could be implemented to prevent potentially catastrophic consequences.
Demands for these simulations are based on real ambitions by terrorist groups to acquire biological and chemical weapons. Most recently, a laptop belonging to a member of ISIS (the Islamic State of Iraq and Syria) was found to contain instructions in Arabic on how to develop biological weapons and weaponize the bubonic plague from infected animals. The nineteen-page document suggested using “small grenades with the virus and throw them in closed areas like metros, soccer stadiums, or entertainment centers.” While these terrorist groups may not yet be capable of carrying out such sophisticated attacks, these types of weapons are definitely on their radar. Al-Qaeda has also attempted to develop chemical weapons, even before the 9/11 attacks, and the United States has regularly...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...